Congresses
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus porta magna justo, vitae egestas dui laoreet at. Etiam sed sollicitudin nisi.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus porta magna justo, vitae egestas dui laoreet at. Etiam sed sollicitudin nisi. Proin efficitur facilisis nulla, non dapibus nisi accumsan at. Sed a libero eu sem malesuada tristique quis iaculis magna. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Mauris rhoncus neque mauris, non sagittis diam eleifend finibus. Vivamus commodo tincidunt tortor quis imperdiet.
mCRPC in focus at ASCO GU 2024
Key highlights from ASCO GU 2024.
ASCU GU 2025
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus porta magna justo, vitae egestas dui laoreet at. Etiam sed sollicitudin nisi. Proin efficitur facilisis nulla, non dapibus nisi accumsan at. Sed a libero eu sem malesuada tristique quis iaculis magna. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Mauris rhoncus neque mauris, non sagittis diam eleifend finibus. Vivamus commodo tincidunt tortor quis imperdiet.
ESMO 2025
Stay tuned
mCRPC at ASCO 2024: Trials and treatments
ASCO 2023 – Developments in metastatic castration-resistant prostate cancer
Developed by EPG Health. This content has been developed independently of the sponsor, Pfizer, which has had no editorial input into the content. EPG Health received funding from the sponsor to help provide healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. This content is intended for healthcare professionals only.